BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (Paris: AELIS)(ISIN: FR0014007ZB4 - ticker: AELIS, PEA-PME eligible), a clinical-stage biopharmaceutical company specialized in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results